Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Clin Med pulm > TB Drugs: > Flashcards

TB Drugs: Flashcards

1
Q

RIPE (1st line drugs)=

A

Rifampin/rifapentine
Isoniazid
Pyrazinamide
Ethambutol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Isoniazid (INH) :

A

MOA
Inhibits bacterial cell wall synthesis
Bactericidal
Indicated in adults and peds for TB treatment and prevention
Contraindicated in patients with acute liver disease
Take on empty stomach
Preg cat C
P450 2C9 inhibitor
Drug interactions: antacids, carbamazepine, phenytoin, ketoconazole, theophylline, valproate, BZDs, warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Isoniazid ARDs:

A

Peripheral neuropathy most common
Dose-related
Most often in malnourished, diabetes, EtOH
Elevated LFTs
10% - 20% usually within first 3 months of treatment
Sometimes progresses to jaundice and fatal hepatitis
Prodrome: anorexia, N/V, fatigue, malaise, weakness
Pyridoxine (vit B6) deficiency
N/V
Less common: agranulocytosis, SLE-like syndrome, fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Isoniazid (INH) side effects:

A

INH
Intestinal upset
Neuropathy
Hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

INH intoxication:

A 
Overdosage
N/V, dizziness, speech slurring, vision blurring, hallucinations
Respiratory distress
CNS depression (stupor to profound coma)
Seizures
Severe metabolic acidosis
hyperglycemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rifampin:

A 
Class: Rifamycin
MOA: Inhibits DNA-dependent RNA polymerase
Bactericidal 
Highly lipophilic
Spectrum: M. tb, N. meningitidis, M. leprae, MRSA, Staph epi.
Indications
Tuberculosis
Meningococcal carriers
Not meningitis due to resistance
Dose for 2 days 
Used in kids and adults
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rifampin ADRs:

A 
*Red-orange body fluids
GI: heartburn, anorexia, N/V, jaundice, 
	flatulence, cramps, diarrhea, CDAD
Thrombocytopenia
HA, fever, drowsiness, fatigue, ataxia, dizziness
Visual disturbances
Dysmenorrhea 
Hyperuricemia
Pruritus, urticaria, rash, Stevens-Johnson, TEN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rifampin DIs:

A 
STRONG 3A4 inducer
Oral contraceptives
Warfarin
Ketoconazole
SMX-TMP
INH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Rifapentine:

A

MOA
inhibits DNA-dependent RNA polymerase in susceptible strains ofM. tuberculosisbut not mammalian cells
Bactericidal
Used with INH for patients 12 yo and older
Not for pregnancy, HIV, kids under 2, resistant M.tb
Induces 3A4, 2C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rifapentine:

A

Hepatotoxicity, hyperbilirubinemia, colored body fluids, CDAD
≥10%: hyperuricemia, pyuria, hematuria, UTI, proteinuria, lymphopenia, neutropenia, anemia, and hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pyrazinamide:

A

Nicotinamide (vitamin B3) analog
Indicated for treatment of active TB in adults and children
Contraindicated in gout or severe liver disease
Half-life 9 – 10 hours
Prolonged in renal/liver impairment
Excreted in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pyrazinamide ADRs:

A 
Hyperuricemia
Inhibits renal excretion of uric acid
Increased LFTs
Rash
Arthralgias, myalgias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ethambutol

A

MOA: inhibits metabolite synthesis, impairing cell metabolism, stopping reproduction
Only useful for mycobacteria
*Used for adjunct treatment of tb
*Not used as monotherapy
Contraindicated in optic neuritis
Drug interactions: Al-containing antacids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ethambutol ADRs:

A

Decreased visual acuity, optic neuritis, optic neuropathy,
Patients should report any visual change
Hyperuricemia, arthralgias, GI, confusion, disorientation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bedaquiline:

A 
First new drug for TB in 40 years
Approved 2012
MOA: inhibits mycobacterial ATP synthase
*Indicated in combo tx for MDR TB
QT prolongation
Increased risk of death (11.4%, 4x placebo in once study)
Hepatotoxicity
CYP 3A4 substrate
ADRS: nausea, arthralgia, HA
Preg cat B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tx of LTBI:

A

LTBI is treated to prevent the development of TB disease
Reduces risk of disease progression
LTBI is treated with multiple medications
Monotherapy no longer recommended

17
Q

High Priority LTBI Tx:

A

High risk groups if positive IGRA or TST result of > 5 mm

Recent close contacts of people with infectious TB disease

People living with HIV

People with chest x-ray findings suggestive of previous TB disease

Patients with organ transplants

Other immunosuppressed patients

18
Q

High Priority LTBI Tx Cont.:

A

High risk groups if positive IGRA or TST result of > 10 mm:
People who have come to U.S. within last 5 years from countries where TB is common
People who inject drugs
People who live or work in high-risk facilities (prisons, homeless shelters, long-term care, etc)
People who work in mycobacteriology laboratories
People with medical conditions that increase risk of TB disease (DM, CRF, cancer, silicosis, gastric bypass)
Children younger than 4 years old
Infants, children, and adolescents exposed to adults in high-risk groups

19
Q

Low priority Tx for LTBI:

A

Individuals without any risk factors generally should not be tested for TB infection

However, individuals with no risk factors who are tested and have a positive IGRA or TST result of >15 mm should be evaluated for LTBI treatment

20
Q

LTBI Tx Reginmens:

A

Preferred regimen is 9 mos daily isoniazid (INH)

Reduces lifetime infection risk from 10% to 1%

21
Q

LTBI TX regimens cont.:

A 
Successful treatment
Adherence to regimen
INH-susceptible TB
No reinfection from exogenous source
Usually dosed 300 mg po daily
Can dose 900 mg BIW with DOT
Give pyridoxine 10 – 50 mg daily to decrease incidence of peripheral neuropathy
22
Q

Rifampin LGTI regimen:

A

Rifampin (RIF) is recommended for people who
Cannot tolerate INH
Have been exposed to INH-resistant TB
RIF should be given daily for 4 months
RIF should not be used with certain combinations of anti-retroviral (ARV) therapy
In some cases, rifabutin may be substituted when RIF cannot be used

23
Q

Tx of LTBI in pregnant women:

A

For most pregnant women, LTBI treatment can be delayed until after delivery, unless they have certain medical conditions

INH has not been shown to have harmful effects on the fetus

Immediate treatment should be considered if woman is living with HIV, has another immunocompromising condition, or is a recent TB contact

Preferred LTBI treatment regimen is 9 months of INH with a vitamin B6 supplement

24
Q

LTBI HIV Tx:

A

Individuals living with HIV should be treated with 9-month regimen of INH

RIF should not be used for people living with HIV who are being treated with certain combinations of ARV
In some cases, rifabutin may be given

25
Q

Pt eval before prescribing:

A

Patient has ever had adverse reactions to LTBI drugs

Patient is currently on medications that may interact with LTBI drugs

Because of the interaction between TB and HIV, all patients should be recommended to undergo HIV screening and be offered an HIV test

26
Q

Goals of active TB tx:

A

Cure patient, minimize risk of death/disability, prevent transmission to others
Provide safest, most effective therapy in shortest time
Prescribe multiple drugs to which the organisms are susceptible
Never treat with a single drug or add single drug to failing regimen
Ensure adherence and completion of therapy

27
Q

adherence:

A

Clinician responsible for completion of therapy

28
Q

DOT=

A

DOT is preferred management strategy for all patients
Can reduce acquired drug resistance, treatment failure, and relapse
Nearly all regimens can be intermittent if given as DOT
DOT reduces total number of doses and encounters
For drug-resistant TB, use daily regimen and DOT
Directly Observed Therapy (DOT)

29
Q

intitial tx phase:

A

First 8 weeks of treatment
Most bacilli killed during this phase
4 drugs used

30
Q

Continuation Tx phase:

A 
After first 8 weeks of TB disease
  treatment
 Bacilli remaining after initial
  phase are treated with at least 2
  drugs
31
Q

Relapse Tx:

A

Occurs when treatment is not
continued for long enough
Surviving bacilli may cause TB
disease at a later time

32
Q

standard 4 drugs for initial phase:

A

Initial phase: standard four drugs (INH, RIF, PZA, EMB) for 8 weeks

33
Q

drug-resistant TB:

A

Caused by organisms resistant to one or more TB drugs
Transmitted same way as drug-susceptible TB, and no more infectious
Delay in detecting drug resistance may prolong period of infectiousness because of delay in starting correct treatment

34
Q

MDR TB:

A

caused by bacteria resistant to isoniazid and rifampin

35
Q

XDR TB:

A

caused by organisms resistant to isoniazid and rifampin, plus fluoroquinolones and ≥1 of the 3 injectable second-line drugs

36
Q

types of drug resistance:

A

Primary resistance develops in persons initially infected with resistant organisms
Secondary (acquired) resistance develops during TB therapy

37
Q

Factors that increase chance of patient having or developing drug-resistant TB:

A

Patient has spent time with someone with active drug-resistant TB disease
Patient does not take all of their medicine or doesn’t take their medicine regularly
Patient develops active TB disease after having taken TB medicine in the past
Patient comes from area of the world where drug-resistant TB is common

38
Q

Monitoring Adverse Reactions

A

Patients should have baseline blood and vision tests to detect problems that may complicate treatment

Children only need vision tests, unless there are other medical conditions that may complicate treatment

Clin Med pulm (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions